Page 36 - Pharma

Thermo Fisher Scientific acquires Affymetrix for $ 1.3 bn

The acquisition of Affymetrix, a leading provider of cellular and genetic analysis products, will strengthen Thermo's position in biosciences and create new opportunities in genetic analysis

Cipla inks distribution pact with US-based BioQ Pharma

As per the agreement, Cipla will be responsible for commercialisation BioQ Pharma's Ropivacaine infusion pharmaceutical in India

Cipla forms a six-member management council

The company has appointed Umang Vohra as its global COO, and expanded role of Samina Vaziralli, executive director, to include strategy and M&A

Smart food packaging can enhance branding: Dr Mosongo Moukwa

Intelligent packaging can leverage Internet of Things (IoT) and Big Data to establish a dynamic interaction with sensing devices on packaging

Sterile medical packaging market to reach $ 35 bn by 2020

Increasing application of sterile packaging in the pharmaceutical & biological sector, aging population, etc are driving the market, says a MarketsandMarkets report

Indian pharmaceutical exports: The growth story

While India continues to be a major exporter of generic to traditional markets such as US, UK, Russia, etc, it is also increasing its reach to other nations like Canada, Germany, Brazil, Japan, etc

Suven Life secures patents in Canada, ARIPO and South Korea

The company has recurred product patents, valid through 2030, for the new chemical entities (NCEs) used in the treatment of disorders associated with neurodegenerative diseases

Merck, Pfizer and Syndax to collaborate for ovarian cancer drug research

Three companies will collaborate to investigate safety, tolerability and preliminary efficacy of avelumab and entinostat in advanced ovarian cancer

Glenmark, Roche agree to end patent litigation for cancer drug Tarceva

As part of the agreement, the companies have ceased all relevant patent litigation on this product and Glenmark has acknowledged the patent rights of Roche

Drug delivery products market in US to reach $ 251 bn by 2019

The market for parenteral drug delivery products is projected to rise over 10 percent annually to $86.5 billion in 2019, says a a Freedonia Group report

Regulatory issues, exchange rate crisis hurting pharma exports: Study

Indian pharma industry is expected to reach $ 55 bn by 2020, but exports may slow down, says a study jointly conducted by Assocham and TechSci Research

Haemophilia treatment market to reach $6.3 bn by 2024

Argentina to emerge as a lucrative region in the crowded haemophilia treatment space as patients will increasingly use recombinant products, says GlobalData report

Zydus buys Zoetis' select brands and Haridwar plant

The move will help Zydus expand its animal health business in India and gain access to manufacturing operations which have also been catering to global markets

Dyadic sells industrial technology business to DuPont

Following the deal, Dyadic intends to focus exclusively on its biopharmaceutical business

Adhesives market growth is driven through disruptive innovation: M V Ganeshan

In this interview M V Ganeshan, MD, Bostik India, focuses on the growth potential of adhesives market and new demand drivers

Cipla launches hepatitis C drug Hepcvir-L

The drug, a ledipasvir-sofosbuvir fixed-dose oral combination, will provide a new interferon and ribavirin-free treatment option to patients affected by genotype 1 hepatitis C virus

Strides Shasun receives DCGI's nod for hepatitis C drug sofosbuvir

In September 2014, Strides had entered into a licensing agreement with Gilead Sciences Inc to launch sofosbuvir (the generic version of Gilead's Sovaldi) in 91 developing countries

Piramal Enterprises buys five brands from Organon India and MSD for Rs 92 cr

Brand acquisitions, by PEL's consumer products division, is expected to aid the division to achieve its aim to be among the top 3 players in the OTC market by 2020

Sun Pharma's Halol plant receives US FDA's warning letter

The company received the warning letter, following the US FDA's inspection of the plant in September last year

Sanofi and Boehringer Ingelheim in talks for business swap

The proposed deal envisage exchange of Sanofi animal health business (Merial) and Boehringer Ingelheim consumer healthcare (CHC) business